AAAAAA
Results:
1-9
|
Results: 9
Authors:
Kaye, EM
Citation: Em. Kaye, Update on white matter genetic disorders - Response, PED NEUROL, 25(4), 2001, pp. 348-348
Authors:
Kaye, EM
Citation: Em. Kaye, Update on genetic disorders affecting white matter, PED NEUROL, 24(1), 2001, pp. 11-24
Authors:
Kang, PB
Hunter, JV
Kaye, EM
Citation: Pb. Kang et al., Lactic acid elevation in extramitochondrial childhood neurodegenerative diseases, J CHILD NEU, 16(9), 2001, pp. 657-660
Authors:
Folkerth, RD
Alroy, J
Bhan, I
Kaye, EM
Citation: Rd. Folkerth et al., Infantile G(M1) gangliosidosis complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination, PEDIATR D P, 3(1), 2000, pp. 73-86
Authors:
Sena-Esteves, M
Camp, SM
Alroy, J
Breakefield, XO
Kaye, EM
Citation: M. Sena-esteves et al., Correction of acid beta-galactosidase deficiency in GM(1) gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: Higher efficiency of release and cross-correction by the murine enzyme, HUM GENE TH, 11(5), 2000, pp. 715-727
Authors:
Selak, MA
de Chadarevian, JP
Melvin, JJ
Grover, WD
Salganicoff, L
Kaye, EM
Citation: Ma. Selak et al., Mitochondrial activity in Pompe's disease, PED NEUROL, 23(1), 2000, pp. 54-57
Authors:
Katsetos, CD
Fincke, JE
Legido, A
Lischner, HW
de Chadarevian, JP
Kaye, EM
Platsoucas, CD
Oleszak, EL
Citation: Cd. Katsetos et al., Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children, CL DIAG LAB, 6(1), 1999, pp. 105-114
Authors:
Libenson, MH
Kaye, EM
Rosman, NP
Gilmore, HE
Citation: Mh. Libenson et al., Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn, PED NEUROL, 20(3), 1999, pp. 185-191
Authors:
Ross, BD
Kaye, EM
Citation: Bd. Ross et Em. Kaye, Creatin' news, NEUROLOGY, 53(2), 1999, pp. 249-250
Risultati:
1-9
|